US FDA Archives - Page 2 of 64 - Express Pharma

Novartis’ kidney disease drug Fabhalta receives US FDA approval

FDA approves first Nalmefene Hydrochloride auto-injector to reverse opioid overdose

Lupin gets USFDA nod for Prednisolone Acetate Ophthalmic Suspension USP

Axxelent receives its first US FDA Establishment Inspection Report (EIR)

US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug

Oral JAK inhibitor LEQSELVI (deuruxolitinib) approved by US FDA for severe alopecia areata treatment

Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study

Zydus receives final US FDA nod for Valsartan Tablets

Zydus gains final FDA nod for Sacubitril and Valsartan Tablets

Alembic gets US FDA nod for Bromfenac Ophthalmic Solution, 0.07 per cent